Recent findings identify three key mechanisms that may reshape prostate cancer management strategy. First, ceramide metabolism—the processing of complex lipid molecules essential for cell death—differs significantly between Black and white men with advanced disease. https://lnkd.in/d-H-YuzP

Researchers at Mayo Clinic developed an AI model that can identify signs of pancreatic cancer on routine CT scans up to three years before diagnosis, helping specialists detect the disease when it is more treatable. https://lnkd.in/em2Tx6mV

On Monday, we held a webinar exploring how we can embed cross-sector signposting to trusted health information. Attendees heard an update on the Diagnosis Connect pilot from Rebecca Sugden at Macmillan Cancer Support. Susannah Ramsay shared details on how Prostate Cancer Research's Infopool reached healthcare professionals across the country. And Peter Foxton from the National Rheumatoid Arthritis Society (NRAS) spoke about the validation of third sector support. PIF members can view the recording on our website: https://lnkd.in/efnydNEz

In a published clinical trial of high-risk patients, CyPath® Lung demonstrated 92% sensitivity, 87% specificity, 88% accuracy and 99% negative predictive value in detecting lung cancer. Whether the test result is “likely” or “unlikely” malignancy, CyPath® Lung provides clinicians with actionable diagnostic information that can support more confident pulmonary nodule management. Learn more: https://lnkd.in/gNRY67m4 #CyPathLung #Pulmonology #Diagnostics #LungCancer

In a published clinical trial of high-risk patients, CyPath® Lung demonstrated 92% sensitivity, 87% specificity, 88% accuracy and 99% negative predictive value in detecting lung cancer. Whether the test result is “likely” or “unlikely” malignancy, CyPath® Lung provides clinicians with actionable diagnostic information that can support more confident pulmonary nodule management. Learn more: https://lnkd.in/gNRY67m4 #CyPathLung #Pulmonology #Diagnostics #LungCancer

In a published clinical trial of high-risk patients, CyPath® Lung demonstrated 92% sensitivity, 87% specificity, 88% accuracy and 99% negative predictive value in detecting lung cancer. Whether the test result is “likely” or “unlikely” malignancy, CyPath® Lung provides clinicians with actionable diagnostic information that can support more confident pulmonary nodule management. Learn more: https://lnkd.in/gNRY67m4 #CyPathLung #Pulmonology #Diagnostics #LungCancer

🧬 Could the thymus be an overlooked marker—and perhaps future target—of biological ageing? This Nature feature highlights evidence linking smaller or absent thymic tissue with higher risks of death, cancer, cardiovascular disease, and poorer outcomes after cancer immunotherapy. 🔬 Regeneration strategies are advancing, but the evidence remains largely correlational. 💡 Clinical pearl: thymic involution may reflect declining immune reserve, yet no rejuvenation therapy is ready for routine care. https://lnkd.in/guKfTfbP

 This week is Alcohol Awareness Week! Did you know that alcohol has been classified as a group 1 carcinogen since 1988? Despite this, only between 10-20% of the public are aware that alcohol consumption can lead to breast and colorectal cancer. At Pharmora, we’ve had the opportunity to support clinical research in cancers and understand both the challenges in developing new treatments and the importance of reducing risk factors. Read on, to learn about alcohol awareness week: https://lnkd.in/emJSipq3

Each 1-point decrease in pretreatment microvascular health was linked to a 31.9% higher acute toxicity risk across three RT cohorts. The association was significant individually only in breast cancer. Full summary → https://lnkd.in/eeQyHDzu

Being able to predict patient outcomes early in a disease course helps providers make important treatment decisions. This is crucial in diseases such as lung cancer, which is the leading cause of cancer-related deaths and is clinically difficult to manage. But a new study in JNM points to an important mortality indicator for metastatic lung cancer: brain metabolism. Learn more here: https://lnkd.in/eU435Cqh Thanks to the research team: Julie Auriac, Irene Buvat, and Fanny Orlhac